New York, Oct. 12, 2017 -- According to the latest market report published by Persistence Market Research titled ‘Home Infusion Therapy Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),’ the global Home Infusion Therapy Devices market is expected to expand at a CAGR of 6.8% during the forecast period 2017–2025. Persistence Market Research delivers key insights and presents a revised forecast of the global Home Infusion Therapy Devices market for an eight year period from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry based demand driving factors, as well as the recent developments of key market participants.
Global Market Research Report Overview on Home Infusion Therapy Devices @ https://www.persistencemarketresearch.com/market-research/home-infusion-therapy-devices-market-102017.asp
The global home infusion therapy devices market is projected to expand at a healthy CAGR of 6.8% in terms of value during the forecast period, revised from the previous CAGR of 5.5%, due to factors regarding which PMR offers useful insights in detail in this report.
A sample of this report is available upon request@ https://www.persistencemarketresearch.com/samples/19111
The Home Infusion Therapy Devices market is segmented based on product type, application, end user and region. On the basis of product type, the market is segmented into disposable elastomeric pumps, insulin pumps, PCA pumps, electronic ambulatory pumps and infusion system pumps accessories. Disposable elastomeric pumps have the highest demand, owing to the higher response rate in home infusion therapy.
Based on application the market is segmented as enteral nutrition, parenteral nutrition, chemotherapy, antibiotic administration and others. Parenteral nutrition segment is slated to record the highest demand, owing to the higher response rate in home infusion therapy.
Based on end user the market is segmented into home care setting and long term care centers. Home care setting is said to hold major market share and register a CAGR of 7.6% in terms of value over the forecast period owing to the increasing availability.
On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia Pacific, and the MEA. North America region dominated the global home infusion therapy devices market, which held around 34.7% of the global market in 2016 and is expected to continue to dominate the overall market partly due to higher awareness and entry of key players into the market by launching different products.
View Report Table of Contents, Figures, and Tables@ https://www.persistencemarketresearch.com/market-research/home-infusion-therapy-devices-market-102017/toc
Vendor Insights
Companies are focusing on collaborations to develop new and more effective products. The product type segment of the home infusion therapy devices market will be boosted by its higher response rate and increasing investments in R&D leading to inorganic growth. The global home infusion therapy devices is highly fragmented owing to the presence of various companies such as B. Braun Melsungen AG., Becton, Dickinson and Company, Johnson & Johnson Private Limited (Animas Corporation), Fresenius Kabi AG, Terumo Corporation, F. Hoffmann-La Roche AG, Smith & Nephew, Pfizer Inc., Baxter International Inc. and Micrel Medical Devices S.A.
Global Home Infusion Therapy Devices Market Report is Available for US$ 4,900
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: [email protected]


Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Baker Hughes Sells Waygate Technologies to Hexagon for $1.45 Billion
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 



